Vita Health Announces $22.5M Series A Funding Round

Supports National Expansion of Critical Mission to Address Suicide Epidemic Vita Health, the first provider of clinically validated suicide prevention through innovative care management, announced today the close of a $22.5M Series A funding round. The funding will support the rapid expansion of life-saving services targeting youth and adults nationwide. The Vita behavioral health care pathways are based on the founding team’s successful clinical trials published in JAMA, The American Journal of Psychiatry, and thousands of patient encounters demonstrating reductions in suicide attempts by more than 60% and deaths by up to 80%. A group of investors from across the healthcare landscape, including LFE Capital, Athyrium Capital Management, Flare Capital Partners, CVS Health Ventures, and CU Healthcare Innovation Fund participated in the round, along with Connecticut Innovations and HopeLab. Vita Health uniquely addresses some of the most challenging and costly areas of healthcare. Their initial mission focused on the ongoing suicide epidemic across all ages. This mission expanded to address the youth mental health crisis beyond suicide for other common conditions such as anxiety and depression. Suicide is the second leading cause of death for teens and college-age students and a top five killer for adults per the Center for Disease Control and Prevention. In 2021 there were over 1.7 million suicide attempts in the US. Vita Health is the only telehealth provider specialized ...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Athyrium Capital Management Connecticut Innovations CU Healthcare Innovation Fund CVS Health Ventures Flare Capital Partners Health IT Funding Health IT Fundings Health IT Investment HopeLab LFE Capita Source Type: blogs